1-11 of 11
Silvia Saumell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bone Marrow Cytokines Concentrations in Myelodysplastic Neoplasms: Its Correlation with the Immune Populations and Clonal Hematopoiesis

Antonieta Molero Yordi, Soraya Peralta Garzón, Laura Gallur, Barbara Tazon, Daniel Medina, Victor Navarro Garces, Maria Julia Montoro, Silvia Saumell, Tamara Jimenez, Félix López Cadenas, Teresa Ezponda, Ana Alfonso Pierola, Felipe Prosper, Maria Diez-Campelo, Olga Salamero, Ana Pérez González, Sara Garrido Paniagua, David Valcarcel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6457.
https://doi.org/10.1182/blood-2023-185616
Published: 2023
Journal Articles

Clinical Impact of the New Bone Marrow Blasts Cutoff Defined By the International Classification Consortium (ICC) in Myeloid Neoplasms with Mutated TP53 gene

Francisco Beas, Maria Sola, Mar Tormo, Ana Riera, Nicolas Diaz Varela, Félix López Cadenas, Nieves Garcia-Gisbert, Sara García, Laura Palomo, Sandra Novoa Jáuregui, Olga Salamero, Ana Pérez-González, Silvia Saumell, Barbara Tazon, Laura Gallur, Gloria Hidalgo-Gómez, Sara Torres-Esquius, Francesc Bosch, Andres Jerez, Maria Julia Montoro, David Valcarcel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3235.
https://doi.org/10.1182/blood-2023-181698
Published: 2023
Journal Articles

Multiomic Characterization of Myelodysplastic Neoplasms (MDS) with Micromegakaryocytes Highlights the Role of EZH2-RUNX1 deregulation in Disease Physiopathology and Response to Targeted Therapies

Miranda Fernandez-Serrano, Alba Mesa, Ignacio Campillo-Marcos, Marta Casado-Pelaez, Shubhra Bhattacharya, Laura Palomo, Wencke Walter, Pau Marin-Escudero, Mar Mallo, Julia Montoro, Francesc Sole, Elisabetta Mereu, Caterina Mata, David Corujo, Torsten Haferlach, Marcus Buschbeck, Manel Esteller, David Valcarcel, Silvia Saumell, Gael Roue
Journal: Blood
Blood (2023) 142 (Supplement 1): 4116.
https://doi.org/10.1182/blood-2023-188848
Published: 2023
Journal Articles

IPSS-M Applicability and Clinical Impact in Decision-Making Process in Real-Life Clinical Practice

Sandra Novoa Jáuregui, Laura Palomo, Ana Pérez, Bárbara Tazón, Maria Julia Montoro, Adoracion Blanco, Silvia Saumell, Laura Gallur, Eugenia Rivero, Sara Garrido, Marc Bosch Schips, Sofia Laura Muzio, Margarita Ortega, Antonieta Molero Yordi, Francesc Bosch, David Valcárcel
Journal: Blood
Blood (2022) 140 (Supplement 1): 6966–6967.
https://doi.org/10.1182/blood-2022-168705
Published: 2022
Journal Articles

Characterization of Terminal Erythroid Differentiation (TED) and Its Prognosis Impact Inpatients with Myelodysplastic Syndrome (MDS)

Marc Bosch Schips, Julia Montoro, Félix López Cadenas, Alba Mesa, Víctor Navarro Garcés, Ana Pérez, Laura Gallur, Silvia Saumell, Mayda Navarrete, Margarita Ortega, Bárbara Tazón, Antonieta Molero, Olga Salamero, Sandra Novoa Jáuregui, Sofia Laura Muzio, Francesc Bosch, David Valcárcel
Journal: Blood
Blood (2022) 140 (Supplement 1): 12308–12310.
https://doi.org/10.1182/blood-2022-157434
Published: 2022
Journal Articles

Bone Marrow Microenvironment Changes in Myelodysplastic Neoplasms and Its Relationship with Clonal Hematopoiesis and Disease Progression

Antonieta Molero Yordi, Soraya Peralta, Laura Gallur, Bárbara Tazón, Víctor Navarro Garcés, Silvia Saumell, Maria Julia Montoro, Olga Salamero, Ana Pérez González, Sara Garrido, Maria Sola, Tamara Jimenez, Félix López Cadenas, Teresa Ezponda, Ana Alfonso-Pierola, Lídia Altimiras, Maria Diez-Campelo, Felipe Prosper, David Valcárcel
Journal: Blood
Blood (2022) 140 (Supplement 1): 4024–4025.
https://doi.org/10.1182/blood-2022-163188
Published: 2022
Journal Articles

Microenvironment Profiling in Myelodysplastic Syndromes and Its Relationship to Clonal Hematopoiesis and Disease Progression

Antonieta Molero Yordi, Bárbara Tazón, Laura Gallur, Silvia Saumell, Tamara Jimenez, Teresa Ezponda, Maria Julia Montoro, Félix López Cadenas, Lídia Altimiras, Carla Sánchez Ruiz, Ana Alfonso, Olga Salamero, Ana Pérez, Soraya Peralta, Maria Diez-Campelo, Felipe Prosper, Francesc Bosch, David Valcarcel
Journal: Blood
Blood (2021) 138 (Supplement 1): 4650.
https://doi.org/10.1182/blood-2021-150104
Published: 2021
Journal Articles

Morphologic Assessment of Terminal Erythroid Differentiation Predicts Outcomes in Myelodysplastic Syndromes

Maria Julia Montoro, MD, Ana Perez, MD, Silvia Saumell, MD PhD, Maida Navarrete, MD, Gael Roue, PhD, Moraima Jimenez, MD, Margarita Ortega, PhD, Bárbara Tazón, PhD, Antonieta Molero, MD, Olga Salamero, MD, Francesc Bosch, MD PhD, David Valcarcel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3011.
https://doi.org/10.1182/blood-2019-123185
Published: 2019
Journal Articles

Acute Myeloid Leukemia with Myelodisplasia-Related Changes (AML-MRC) Defined Only By Morphological Findings May Not Represent a Poor Prognosis AML

Ana Pérez, MD, Olga Salamero, MD, Helena Pomares, MD PhD, Maria Julia Montoro, MD, Montserrat Arnan Sangerman, MD PhD, Laura Gallur, MD, María Laura Fox, MD, Elisa Roldan, MD, Antonieta Molero, MD, Guillermo Ortí, MD, Mayda Navarrete, MD, Esther Alonso, MD, Bárbara Tazón, PhD, M Moraima Jimenez, MD, Margarita Ortega, PhD, Adoración Blanco, PhD, Gael Roue, PhD, Pere Barba, MD PhD, Silvia Saumell, MD PhD, David Valcárcel, MD PhD, Francesc Bosch, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2612.
https://doi.org/10.1182/blood-2019-129153
Published: 2019
Journal Articles

An IPSS-R Cutpoint of 3 Stratified Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) Patients (pts) into Two Risk Groups

Julia Montoro, Helena Pomares, Brayan Merchan, Antonieta Molero, Silvia Saumell, Esther Alonso, Mónica Fernández, Laura Gallur, Javier Grau, Olga Salamero, Adoración Blanco, Anna Varela, Elisa Roldán, Anna Sureda, Francesc Bosch, Montserrat Arnan Sangerman, David Valcarcel
Journal: Blood
Blood (2017) 130 (Supplement 1): 5306.
https://doi.org/10.1182/blood.V130.Suppl_1.5306.5306
Published: 2017
Journal Articles

Modified-CHOP with Reduced Dose of Non-Pegylated Liposomal Doxorubicin ± Rituximab in First Line Treatment for Elderly Patients with Aggressive Lymphoma Non Suitables for Standard Chemotherapy.

Eva Gimeno, Blanca Sánchez, Alberto Alvarez, Carme Pedro, Eugenia Abella, Miquel Gomez, Silvia Saumell, Josep Comin, Carles Besses, Antonio Salar
Journal: Blood
Blood (2009) 114 (22): 4752.
https://doi.org/10.1182/blood.V114.22.4752.4752
Published: 2009